"Daijoubu is such a wonderful word." But—is that really true? There was an event that made me think about that. When you ...

Initial Phase 1b data highlight promising clinical activity in patients with PROC and support continued clinical development of CUSP06At the ...

VAX-31 Met All Prespecified Primary Endpoints Across Age Groups Studied Compared to Prevnar 20® (PCV20) and/or Capvaxive® (PCV21) Prespecified Co-Primary Immunogenicity Endpoints: In Adults 50 and ...

(Nasdaq: PCVX), a clinical-stage vaccine innovation company, today announced it will host a webcast and conference call tomorrow, October 5, 2026 at 8:00 a.m. ET / 5:00 a.m. PT to present topline data ...

Initial Phase 1b data highlight promising clinical activity in patients with PROC and support continued clinical development of CUSP06 At the September 23, 2026, data cutoff, CUSP06 achieved a 62% ...

Hello. I am Taku-sensei, a teacher who teaches Japanese (modern and classical literature) at a private high school and also ...

For learners looking for an app to practice Spanish verb conjugation, MuyVerbs by 2Day Communications GmbH combines ...

The MICVO oncology drug shows promising early data; dosage optimization is ahead. Click for more on PYXS stock.

A single patient with one of the rarest and most aggressive salivary gland malignancies has provided oncologists with an ...

In this video we are going to explore an easy example of completing the square vs a hard example where we will need to use ...

Transaction value based on SEC Form 4 weighted average sale price ($61.20); post-transaction value based on the September 2 market close ($61.58). Vaxcyte is a clinical-stage biotechnology company ...

A landmark real-world study from China has delivered striking news for patients with one of the most common forms of blood ...